These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11807957)

  • 1. Ribozyme-mediated downregulation of human metallothionein II(a) induces apoptosis in human prostate and ovarian cancer cell lines.
    Tekur S; Ho SM
    Mol Carcinog; 2002 Jan; 33(1):44-55. PubMed ID: 11807957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells.
    Yamasaki M; Nomura T; Sato F; Mimata H
    Oncol Rep; 2007 Nov; 18(5):1145-53. PubMed ID: 17914565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of hammerhead ribozymes targeting rodent metallothionein-I and -II ribonucleic acid.
    Lee KF; Lau KM; Ho SM
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):294-301. PubMed ID: 10620487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells.
    Abdel-Mageed A; Agrawal KC
    Cancer Gene Ther; 1997; 4(3):199-207. PubMed ID: 9171939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer.
    Dorai T; Olsson CA; Katz AE; Buttyan R
    Prostate; 1997 Sep; 32(4):246-58. PubMed ID: 9288183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of insulin-like growth factor-II in cancer growth and progression evidenced by the use of ribozymes and prostate cancer progression models.
    Guo N; Ye JJ; Liang SJ; Mineo R; Li SL; Giannini S; Plymate SR; Sikes RA; Fujita-Yamaguchi Y
    Growth Horm IGF Res; 2003 Feb; 13(1):44-53. PubMed ID: 12550081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant defective adenoviral agent expressing anti-bcl-2 ribozyme promotes apoptosis of bcl-2-expressing human prostate cancer cells.
    Dorai T; Perlman H; Walsh K; Shabsigh A; Goluboff ET; Olsson CA; Buttyan R
    Int J Cancer; 1999 Sep; 82(6):846-52. PubMed ID: 10446452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribozyme targeted on HPV16E6 mRNA induced apoptosis on human cervical carcinoma CaSKi cells.
    Zheng YF; Zhang JR
    Ai Zheng; 2003 May; 22(5):458-62. PubMed ID: 12753702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallothionein overexpression in human trophoblastic cells protects against cadmium-induced apoptosis.
    McAleer MF; Tuan RS
    In Vitr Mol Toxicol; 2001; 14(1):25-42. PubMed ID: 11689154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.
    Wei H; Desouki MM; Lin S; Xiao D; Franklin RB; Feng P
    Mol Cancer; 2008 Jan; 7():7. PubMed ID: 18208603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
    Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
    Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific down-regulation of HER-2/neu mediated by a chimeric U6 hammerhead ribozyme results in growth inhibition of human ovarian carcinoma.
    Lui VW; He Y; Huang L
    Mol Ther; 2001 Feb; 3(2):169-77. PubMed ID: 11237673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of c-fms proto-oncogene in an ovarian carcinoma cell line by a hammerhead ribozyme.
    Yokoyama Y; Morishita S; Takahashi Y; Hashimoto M; Tamaya T
    Br J Cancer; 1997; 76(8):977-82. PubMed ID: 9376277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrovirus-mediated transfer of anti-MDR1 ribozymes fully restores chemosensitivity of P-glycoprotein-expressing human lymphoma cells.
    Wang FS; Kobayashi H; Liang KW; Holland JF; Ohnuma T
    Hum Gene Ther; 1999 May; 10(7):1185-95. PubMed ID: 10340550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.
    Wong HC; Wong CC; Sagineedu SR; Loke SC; Lajis NH; Stanslas J
    Cell Biol Toxicol; 2014 Oct; 30(5):269-88. PubMed ID: 25070834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MicroRNA-16 regulates the proliferation, invasion and apoptosis of ovarian epithelial carcinoma cells in vitro].
    Tang R; Cui ZM; Lou YH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):846-50. PubMed ID: 23302126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal and copper-induced expression of metallothionein isoform 1,2 and 3 genes in epithelial cancer cells: The role of tumor suppressor p53.
    Ostrakhovitch EA; Song YP; Cherian MG
    J Trace Elem Med Biol; 2016 May; 35():18-29. PubMed ID: 27049123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of blocking androgen receptor expression with specific hammerhead ribozyme on in vitro growth of prostate cancer cell line.
    Tong Q; Zhao J; Chen Z; Zeng F; Lu G
    Chin Med J (Engl); 2003 Oct; 116(10):1515-8. PubMed ID: 14570613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein].
    Li Y; Mi C
    Ai Zheng; 2003 Jun; 22(6):586-91. PubMed ID: 12948406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.